Is Acrux Limited (ARUXF) a Buy, Sell, or Hold?
OTC : ARUXF
Acrux Limited
$0.0169 USD
$0 (0.0%)
- Volume
- 40K
- Average Volume
- 30.52K
- Market Capitalization
- $6.78M
- P/E Ratio
- -1.55
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.05
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.35
Company Overview
OTC
John Warmbrunn
Biotechnology
Healthcare
ARUXF
43
AU
USD
Liquidity Metrics
3.03
1.35
1.35
0.46
0.00
Sales & Valuation
$1.19M
1.89
3.08
-2.19
-0.01
Profitability
-$0.0169
-$5.94M
-83.81%
-105.48%
-211.88%
-49.76%
P/E Metrics
-1.55
-0.02
-0.02
Analyst Price Target & Rating
1/5
0 Analysts
%
Financial Health Scores
-44.90
3/9
$711.72K
$4.73M
$3.53M
-$14.61M
Key Metrics (TTM)
$7.42M
2.64
-1.60
1.35
-211.88%
-120.27%
-57.35%
-51.23%
20 days
Company Executives
| Name | Title |
|---|---|
| John Warmbrunn | MD, Chief Executive Officer & Director |
| Mark Hyman | Project & Technical Development Director |
| Felicia Colagrande | Product Development & Technical Affairs Director |
| Joanna Johnson ICAA | Chief Financial Officer & Company Secretary |
Poll Results
No votes yet today — be the first to share your view!
About Acrux Limited (OTC:ARUXF) Stock
Acrux Limited, alongside its affiliated entities, specializes in the global development and commercialization of generic and topical pharmaceutical products. The company's reach extends across international markets, including Australia, Europe, and the United States. A significant part of its offerings includes diverse testosterone therapies, available in various forms such as oral and buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels, all aimed at treating adult men with low or absent testosterone levels. Additionally, Acrux provides estradiol sprays, sold under the brand names Evamist and Lenzetto, specifically formulated for women experiencing hot flashes associated with menopause. The company, established in 1998, is headquartered in West Melbourne ... , Australia.
Frequently Asked Questions
-
What is the current Acrux Limited (ARUXF) stock price?
-
Acrux Limited(OTC:ARUXF) stock price is $0.0169 in the last trading session. During the trading session, ARUXF stock reached the peak price of $0.0504 while $0.001 was the lowest point it dropped to. The percentage change in ARUXF stock occurred in the recent session was 0.0% while the dollar amount for the price change in ARUXF stock was $0.
-
ARUXF's industry and sector of operation?
-
The OTC listed ARUXF is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ARUXF?
-
John Warmbrunn | MD, Chief Executive Officer & Director
Mark Hyman | Project & Technical Development Director
Felicia Colagrande | Product Development & Technical Affairs Director
Joanna Johnson ICAA | Chief Financial Officer & Company Secretary
| -
How many employees does ARUXF have?
-
Number of ARUXF employees currently stands at 43. ARUXF operates from 103-113, Stanley Street, West Melbourne, VIC 3003, AU.
-
Link for ARUXF official website?
-
Official Website of ARUXF is: https://www.acrux.com.au
-
How do I contact ARUXF?
-
ARUXF could be contacted at phone #61 3 8379 0100 and can also be accessed through its website. ARUXF operates from 103-113, Stanley Street, West Melbourne, VIC 3003, AU.
-
How many shares of ARUXF are traded daily?
-
The average number of ARUXF shares traded daily for last 3 months was 30.52K.
-
What is the market cap of ARUXF currently?
-
The market value of ARUXF currently stands at $6.78M with its latest stock price at $0.0169